NCT00003176 - Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 25, 1998

Primary Completion Date

December 3, 2001

Study Completion Date

January 6, 2004

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

carmustine

DRUG

temozolomide

Trial Locations (10)

Children's Hospital of Pittsburgh, Pittsburgh

University of Pittsburgh Cancer Institute, Pittsburgh

University of Wisconsin Comprehensive Cancer Center, Madison

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

UCSF Cancer Center and Cancer Research Institute, San Francisco

Dana-Farber Cancer Institute, Boston

University of Michigan Comprehensive Cancer Center, Ann Arbor

Simmons Cancer Center - Dallas, Dallas

University of Texas - MD Anderson Cancer Center, Houston

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER